about
Gene therapy with an AAV vector expressing human IL-2 alters immune system homeostasis in humanized mice.Dual AAV gene therapy for Duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model.Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.Nanotherapy for Duchenne muscular dystrophy.Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases.AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model.A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy.Viral Vectors, Engineered Cells and the CRISPR Revolution.Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells.Micro-dystrophin gene therapy goes systemic in Duchenne muscular dystrophy patients.Cardiac specific expression of ∆H2-R15 mini-dystrophin normalized all ECG abnormalities and the end-diastolic volume in a 23-m-old mouse model of Duchenne dilated cardiomyopathy.In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents.Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
P2860
Q38616032-0A19CB83-E211-493A-AE9A-450B50E811EBQ38631895-02599B24-0997-4A94-80AC-B1A68DC14F48Q38645275-170770D2-3908-4881-A7A9-FFA72EEC983EQ39233936-1F972342-B213-4E65-8C1F-F8B8F8B6174AQ39409371-5EB2ACBC-9A28-4AEE-82A5-F529D7FFBA63Q40039939-2B585E0F-8B4F-43A5-B22B-23134300D959Q40277560-56C8FFEC-EB7A-4537-A68D-6E3CD9082DD0Q41171772-20EDA863-AEE5-45F3-8BCC-5FFC73EF856EQ45874356-A52464BB-ABA4-4761-AE19-01B57A8A55A5Q48507292-E5B33A83-82BC-4CE5-872A-8B4924FDE8BFQ49213911-2808815E-9913-4747-807B-8A32A697A16FQ49797651-D0500E27-13B6-4F9B-BD67-87B1D1AEC4DEQ50058440-F77679E0-49AA-4F5A-8416-B90D93965199Q50233651-D1B41D97-BAC3-42FB-89BD-FB3260B3348EQ54944159-1963BD70-21D8-43FE-ADA3-F8A5CD094FA3Q57039821-6E1EE7EA-5AD9-4452-815B-7B17D8709EDB
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Systemic delivery of adeno-associated viral vectors.
@en
type
label
Systemic delivery of adeno-associated viral vectors.
@en
prefLabel
Systemic delivery of adeno-associated viral vectors.
@en
P2860
P1476
Systemic delivery of adeno-associated viral vectors.
@en
P2093
Dongsheng Duan
P2860
P356
10.1016/J.COVIRO.2016.07.006
P577
2016-07-23T00:00:00Z